We began as a dental pharmaceutical company focused on preventing dental decay in high risk adults visiting the dentist. After years of observing Prevora’s long-term benefits in high risk adults, we are expanding Prevora’s indication to periodontal disease and its use in chronic disease management.
Truly effective and safe oral health prevention which is integrated into the healthcare of patients with Special Needs, Complex Needs and Geriatric Needs. This involves 4 in 10 adults past mid-life in North America and Western Europe who are at high risk of poor oral health – some 125 million people. The largest unmet need in pharmaceuticals.